Histogen Inc.
HSTO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $220 | $303 | $517 | $267 |
| - Cash | $4,573 | $7,259 | $9,658 | $12,109 |
| + Debt | $0 | $4,514 | $4,575 | $4,631 |
| Enterprise Value | -$4,353 | -$2,442 | -$4,566 | -$7,211 |
| Revenue | $5 | $5 | $5 | $4 |
| % Growth | 0% | 0% | 25% | – |
| Gross Profit | -$57 | -$33 | -$33 | -$34 |
| % Margin | -1,140% | -660% | -660% | -850% |
| EBITDA | -$3,830 | -$2,050 | -$3,436 | -$2,930 |
| % Margin | -76,600% | -41,000% | -68,720% | -73,250% |
| Net Income | -$3,851 | -$2,092 | -$3,473 | -$2,987 |
| % Margin | -77,020% | -41,840% | -69,460% | -74,675% |
| EPS Diluted | -0.9 | -0.49 | -0.81 | -0.93 |
| % Growth | -83.7% | 39.5% | 12.9% | – |
| Operating Cash Flow | -$2,689 | -$2,396 | -$2,550 | -$2,439 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$2,689 | -$2,396 | -$2,550 | -$2,440 |